AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.26 $2.99 Monday, 20th May 2024 XTLB stock ended at $2.60. This is 3.45% less than the trading day before Friday, 17th May 2024. During the day the stock fluctuated 12.22% from a day low at $2.43 to a day high of $2.72.
90 days $0.768 $4.99
52 weeks $0.750 $4.99

Historical XTL Biopharmaceuticals Ltd. prices

Date Open High Low Close Volume
Mar 09, 2023 $1.28 $1.29 $1.21 $1.28 2 316
Mar 08, 2023 $1.34 $1.38 $1.28 $1.28 1 636
Mar 07, 2023 $1.29 $1.39 $1.28 $1.31 3 694
Mar 06, 2023 $1.23 $1.27 $1.23 $1.27 528
Mar 03, 2023 $1.23 $1.31 $1.23 $1.31 1 056
Mar 02, 2023 $1.36 $1.41 $1.23 $1.27 4 326
Mar 01, 2023 $1.29 $1.34 $1.29 $1.32 1 810
Feb 28, 2023 $1.25 $1.40 $1.25 $1.40 6 028
Feb 27, 2023 $1.25 $1.26 $1.24 $1.24 524
Feb 24, 2023 $1.34 $1.34 $1.34 $1.34 0
Feb 23, 2023 $1.32 $1.34 $1.32 $1.34 206
Feb 22, 2023 $1.26 $1.37 $1.25 $1.37 3 848
Feb 21, 2023 $1.33 $1.42 $1.33 $1.42 647
Feb 17, 2023 $1.35 $1.45 $1.35 $1.42 29 137
Feb 16, 2023 $1.36 $1.38 $1.34 $1.37 8 213
Feb 15, 2023 $1.24 $1.34 $1.24 $1.33 1 536
Feb 14, 2023 $1.24 $1.24 $1.23 $1.23 393
Feb 13, 2023 $1.31 $1.31 $1.31 $1.31 0
Feb 10, 2023 $1.32 $1.31 $1.26 $1.31 473
Feb 09, 2023 $1.35 $1.35 $1.35 $1.35 0
Feb 08, 2023 $1.35 $1.35 $1.35 $1.35 0
Feb 07, 2023 $1.35 $1.35 $1.35 $1.35 0
Feb 06, 2023 $1.35 $1.35 $1.35 $1.35 0
Feb 03, 2023 $1.35 $1.35 $1.35 $1.35 0
Feb 02, 2023 $1.25 $1.35 $1.25 $1.35 3 703

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use XTLB stock historical prices to predict future price movements?
Trend Analysis: Examine the XTLB stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the XTLB stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd. XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCD... XTLB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT